Comparison of probability of target attainment calculated by Monte Carlo simulation with meropenem clinical and microbiological response for the treatment of complicated skin and skin structure infections
- 6 June 2006
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 28 (1) , 62-68
- https://doi.org/10.1016/j.ijantimicag.2006.02.018
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an updateJournal of Antimicrobial Chemotherapy, 2005
- Optimizing antimicrobial pharmacodynamics: dosage strategies for meropenemClinical Therapeutics, 2004
- Optimizing Pharmacodynamic Target Attainment Using the MYSTIC Antibiogram: Data Collected in North America in 2002Antimicrobial Agents and Chemotherapy, 2004
- Use of Monte Carlo Simulations To Select Therapeutic Doses and Provisional Breakpoints of BAL9141Antimicrobial Agents and Chemotherapy, 2004
- Predicting efficacy of antiinfectives with pharmacodynamics and Monte Carlo simulationThe Pediatric Infectious Disease Journal, 2003
- Pharmacokinetics-Pharmacodynamics of Cefepime and Piperacillin- Tazobactam against Escherichia coli and Klebsiella pneumoniae Strains Producing Extended-Spectrum β-Lactamases: Report from the ARREST ProgramAntimicrobial Agents and Chemotherapy, 2003
- Use of Preclinical Data for Selection of a Phase II/III Dose for Evernimicin and Identification of a Preclinical MIC BreakpointAntimicrobial Agents and Chemotherapy, 2001
- The Pharmacodynamics of β‐LactamsClinical Infectious Diseases, 1998
- Interval estimation for the difference between independent proportions: comparison of eleven methodsStatistics in Medicine, 1998
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976